Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2019 Filed Dec 4, 2019 21:39 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001338 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 02:27 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001334 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,408 Underlying: Common Stock · 6,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 02:27 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $22.80 | $136,800.00 |
DisclosureSEC source: 0000898432-19-001334 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.75 to $22.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 02:27 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001334 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 25, 2019 Filed Dec 4, 2019 21:39 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001338 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,568 Underlying: Common Stock · 6,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 25, 2019 Filed Dec 4, 2019 21:39 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $22.80 | $136,800.00 |
DisclosureSEC source: 0000898432-19-001338 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.75 to $22.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 25, 2019 Filed Dec 4, 2019 21:39 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001338 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 22:25 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001329 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 22:25 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.25 | $139,500.00 |
DisclosureSEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 22:25 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,840 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,568 Underlying: Common Stock · 1,840 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,160 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,160 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.25 | $139,500.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 22:25 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001329 · form4.xml · derivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 22:25 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.28 | $139,680.00 |
DisclosureSEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.20 to $23.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 22:25 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 21, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · derivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 21, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.28 | $139,680.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.20 to $23.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 21, 2019 Filed Dec 4, 2019 21:36 UTC Amendment |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 20, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 20, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.42 | $140,520.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $23.40 to $23.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 20, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 22:10 UTC |
VUOTO ANTHONYDirector
|
SaleCommon Stock | 5,288 | $23.40 | $123,739.20 |
DisclosureSEC source: 0000898432-19-001328 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,029 F1 · price: This transaction was executed in multiple trades at prices ranging from $23.255 to $23.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.05 | $138,300.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $22.86 | $137,160.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.80 to $23.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 23:15 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.02 | $138,120.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.29 | $139,740.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.07 to $23.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,160 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.68 | $142,080.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.37 to $23.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 22:44 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 12, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,300 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,160 Underlying: Common Stock · 11,300 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 12, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 11,300 | $23.98 | $270,974.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $23.60 to $24.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 11,300 | $0.93 | $10,509.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,668 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,460 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.02 | $138,120.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,460 Underlying: Common Stock · 6,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $23.06 | $138,360.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.81 to $23.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 22:18 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 23:47 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001298 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,460 Underlying: Common Stock · 4,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 23:47 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 4,000 | $24.10 | $96,400.00 |
DisclosureSEC source: 0000898432-19-001298 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.85 to $24.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.